Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, in other Central and Eastern European countries, in Turkey, in North Africa and in the United States of America. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties within the urogenital therapeutic area and of treatments for rare diseases. Consolidated revenue for 2015 was € 1,047.7 million, operating income was € 278.5 million and net income was € 198.8 million.

Company Growth (employees)
Milano, IT
Size (employees)
4,116 (est)
Recordati was founded in 1926 and is headquartered in Milano, IT

Recordati Office Locations

Recordati has an office in Milano
Milano, IT (HQ)
1 Via Matteo Civitali

Recordati Financials and Metrics

Recordati Financials


Market capitalization (31-Oct-2017)

8.2 b

Closing share price (31-Oct-2017)

Recordati's current market capitalization is €8.2 b.
Show all financial metrics

Recordati Market Value History

Recordati's Web-traffic and Trends

Recordati Online and Social Media Presence

Recordati Company Life and Culture

You may also be interested in